Search Within

Amreen Husain

Formats
  1. Meeting Abstract (11)
  2. Journal Article (8)
Groups
  1. Surgery (8)
  2. Gynecology Disease Management Team (5)
  3. Biostatistics Service (4)
  4. Center for Pancreatic Cancer Research (4)
  5. Department of Medicine (4)
  6. Epidemiology and Biostatistics (4)

More Groups

People
  1. David Spriggs (15)
  2. Nestor Rosales (6)
  3. Richard Barakat (6)
  4. Gary Schwartz (5)
  5. William Hoskins (5)
  6. Carol Aghajanian (4)

More People

Years
  1. 2000 (4)
  2. 1999 (3)
  3. 1998 (7)
  4. 1997 (4)
  5. 1996 (1)
Publications
  1. Gynecologic Oncology (9)
  2. Proceedings of the American Association for Cancer Research Annual Meeting (7)
  3. Clinical Cancer Research (2)
  4. Cancer Research (1)
Publishers
  1. American Association for Cancer Research (10)
  2. Elsevier Inc. (9)

Results (19)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • MLH1 and MSH2 expression and correlation with prognostic factors in ovarian cancer
    Meeting Abstract

    Samimi, G.; Fink, D.; Varki, N. M.; Husain, A.; Hoskins, W. J.; Alberts, D. S.; Howell, S. B.
    Proceedings of the American Association for Cancer Research Annual Meeting (2000)

    Fulltext@MSK | Save
  • Immunohistochemical analysis of the expression of NFkappaB in platinum resistant ovarian cancer
    Meeting Abstract

    Yessaian, A. A.; Husain, A.; Federici, M.; Spriggs, D.
    Proceedings of the American Association for Cancer Research Annual Meeting (2000)

    Fulltext@MSK | Save
  • Continent urinary diversion and low-rectal anastomosis in patients undergoing exenterative procedures for recurrent gynecologic malignancies
    Journal Article

    Husain, A.; Curtin, J.; Brown, C.; Chi, D.; Hoskins, W.; Poynor, E.; Alektiar, K.; Barakat, R.
    Gynecologic Oncology (2000)

    Fulltext@MSK | Save
  • Analysis of MLH1 and MSH2 expression in ovarian cancer before and after platinum drug-based chemotherapy
    Journal Article

    Samimi, G.; Fink, D.; Varki, N. M.; Husain, A.; Hoskins, W. J.; Alberts, D. S.; Howell, S. B.
    Clinical Cancer Research (2000)

    Fulltext@MSK | Save
  • Phase II trial of intraperitoneal cisplatin and mitoxantrone in patients with persistent ovarian cancer
    Meeting Abstract

    Husain, A.; Sabbatini, P.; Fennelly, D.; Aghajanian, C.; Barakat, R.; Curtin, J.; Venkatraman, E.; Hoskins, W.; Markman, M.
    Gynecologic Oncology (1999)

    Fulltext@MSK | Save
  • Gastrointestinal toxicity is not a major complication of standard dose paclitaxel therapy
    Journal Article

    Husain, A.; Spriggs, D.; Barakat, R.
    Gynecologic Oncology (1999)

    Fulltext@MSK | Save
  • Phase II trial of intraperitoneal cisplatin and mitoxantrone in patients with persistent ovarian cancer
    Journal Article

    Husain, A.; Sabbatini, P.; Spriggs, D.; Fennelly, D.; Aghajanian, C.; Barakat, R.; Curtin, J.; Venkatraman, E.; Hoskins, W.; Markman, M.
    Gynecologic Oncology (1999)

    Fulltext@MSK | Save
  • BRCA1 upregulation is associated with repair mediated resistance to cisplatin (CDDP) and antisense suppression of BRCA1 increases sensitivity to CDDP, decreases DNA damage repair proficiency and enhances apoptosis
    Meeting Abstract

    Husain, A.; He, G.; Venkatraman, E. S.; Spriggs, D. R.
    Proceedings of the American Association for Cancer Research Annual Meeting (1998)

    Fulltext@MSK | Save
  • Clostridium difficile infection in patients treated with paclitaxel-based chemotherapy
    Meeting Abstract

    Husain, A.; Makhija, S.; Spriggs, D. R.; Barakat, R. R.
    Gynecologic Oncology (1998)

    Fulltext@MSK | Save
  • Restoration of wild-type p53 gene increases sensitivity to CDDP in an ovarian cancer cell line
    Meeting Abstract

    Husain, A.; Makhija, S.; Rosales, N.; Spriggs, D. R.
    Gynecologic Oncology (1998)

    Fulltext@MSK | Save